Buhler Stéphane, Baldomero Helen, Ferrari-Lacraz Sylvie, Nunes José Manuel, Sanchez-Mazas Alicia, Massouridi-Levrat Stravroula, Heim Dominik, Halter Jörg, Nair Gayathri, Chalandon Yves, Schanz Urs, Güngör Tayfun, Nicoloso Grazia, Tiercy Jean-Marie, Passweg Jakob, Villard Jean
Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, Geneva, Switzerland.
Anthropology Unit, AGP Laboratory, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland.
Bone Marrow Transplant. 2019 Oct;54(10):1701-1709. doi: 10.1038/s41409-019-0520-6. Epub 2019 Apr 5.
HLA matching is a critical factor for successful allogeneic hematopoietic stem cell transplantation. For unrelated donor searches, matching is usually based on high-resolution typing at five HLA loci, looking for a 10/10 match. Some studies have proposed that further matching at the haplotype level could be beneficial for clinical outcome. In this study, we determined the phased haplotypes of 291 patients using family members and segregation analysis. The sum of ranks of the haplotypes carried by patients was used as a surrogate predictor of a successful unrelated donor search. The putative impact of haplotypes was then analyzed in a cohort of 211 recipients transplanted with 10/10 matched unrelated donors. A logistic regression analysis showed a highly significant effect of the haplotypes in the outcome of a search, but we did not find any significant effect on overall survival, graft versus host disease or relapse/progression following HSCT. This study provides useful data for the optimization of unrelated bone marrow donor searches, but does not confirm previous reports that matching at the haplotype level has a clinical impact following HSCT. Due to the extreme polymorphism of HLA genes, further studies are warranted to better understand the many factors at play.
人类白细胞抗原(HLA)配型是异基因造血干细胞移植成功的关键因素。在寻找无关供者时,配型通常基于五个HLA位点的高分辨率分型,寻求10/10全相合。一些研究提出,在单倍型水平上进一步配型可能对临床结局有益。在本研究中,我们利用家庭成员和分离分析确定了291例患者的分阶段单倍型。患者携带的单倍型的秩和用作成功寻找无关供者的替代预测指标。然后在一组接受10/10全相合无关供者移植的211例受者中分析单倍型的假定影响。逻辑回归分析显示单倍型对寻找结果有高度显著影响,但我们未发现其对造血干细胞移植后的总生存、移植物抗宿主病或复发/进展有任何显著影响。本研究为优化无关骨髓供者寻找提供了有用数据,但未证实先前关于单倍型水平配型在造血干细胞移植后具有临床影响的报道。由于HLA基因的极端多态性,有必要进行进一步研究以更好地了解其中的诸多影响因素。